Entries tagged with “pharmaceutical-industry”

Articles

5 articles found for pharmaceutical-industry:

  • Gearing up for the Next Wave of AI in Pharmaceutical Industry – From Cost-based to Value-based models

    Artificial intelligence (AI) is reshaping business operations in the health industry. Amid the ever-evolving AI infrastructure, growth in tech-savvy patients and availability of big data, the industry is set to make a transition from using AI for controlling costs to utilizing it for improving patient care. The AI in healthcare market is estimated to reach $6.6Bn in 2021 from $600Mn in 2014, recording a CAGR of 40%; in the five years subsequent to 2021, the market is estimated to grow by more than 10 times.1 In this article, we provide insights on the applications of AI in patient-centric models for improving patient care, from diagnosis to post-treatment care.

  • Will Indian Generics Makers Target Niche Pharma Markets in the US?

    With growing interest in low-cost healthcare options, the US pharma market could be a more lucrative opportunity than their domestic markets for Indian generic drug makers.

  • Pharma Deal-Making: In the Pink Of Health

    Deal-making in the global pharmaceuticals sector is booming, with no signs of slowing down.

  • Edible Vaccines – A Research Area Waiting to Explode

    Ease of administration and patient compliant due to oral delivery

  • Oral Insulin

    Diabetes is a type of metabolic disorder caused by an insulin imbalance in the body either due to insufficient production of insulin by the pancreas or due to body cells not responding to the insulin that is produced.


Blogs

6 blog posts found for pharmaceutical-industry:


Infographics

4 infographics found for pharmaceutical-industry:


Special Reports

3 special reports found for pharmaceutical-industry:

  • Nanoparticle Drug Delivery Systems For Cancer Treatment

    Nanotechnology is a rapidly evolving domain solving various issues associated with conventional drug therapeutics, including poor water solubility

  • Therapeutic Vaccines for Alzheimer’s — Are We Close Enough?

    Alzheimer's Disease (AD), one of the most common causes of dementia, accounts for nearly 70% of documented cases of Dementia across the world.

    The pharmaceutical industry is exploring all available options to develop a successful therapy, and the global market for Alzheimer’s treatment is expected to grow at a CAGR of 10.5%, from $4.9 billion in 2013 to $13.3 billion by 2023.

    This report covers current research into therapeutic vaccines for Alzheimer’s Disease (AD), with topics that include market drivers, challenges associated with developing safe next-gen therapeutics, vaccines and therapies currently under development, as well as the technology and commercial ecosystem for AD therapy.

  • Pharma Patent Monetization: New Approaches, New Synergies

    Patents are the undisputable kingmakers in the life sciences industry.